HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Application of oligonucleotide array CGH in the detection of a large intragenic deletion in POLG associated with Alpers Syndrome.

Abstract
Mutations in the polymerase γ (POLG) gene are among the most common causes of mitochondrial disease and more than 160 POLG mutations have been reported. However, a large proportion of patients suspected of having POLG mutations only have one (heterozygous) definitive pathogenic mutation identified. Using oligonucleotide array CGH, we identified a compound heterozygous large intragenic deletion encompassing exons 15-21 of this gene in a child with Alpers syndrome due to mtDNA depletion. This is the first large POLG deletion reported and the findings show the clinical utility of using array CGH in cases where a single heterozygous mutation has been identified in POLG.
AuthorsAlison G Compton, Christopher Troedson, Meredith Wilson, Peter G Procopis, Fang-Yuan Li, Ellen K Brundage, Taro Yamazaki, David R Thorburn, Lee-Jun C Wong
JournalMitochondrion (Mitochondrion) Vol. 11 Issue 1 Pg. 104-7 (Jan 2011) ISSN: 1872-8278 [Electronic] Netherlands
PMID20708716 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 Mitochondria Research Society. Published by Elsevier B.V. All rights reserved.
Chemical References
  • DNA, Mitochondrial
  • DNA Polymerase gamma
  • DNA-Directed DNA Polymerase
  • POLG protein, human
Topics
  • Child, Preschool
  • Comparative Genomic Hybridization (methods)
  • DNA Polymerase gamma
  • DNA, Mitochondrial (genetics)
  • DNA-Directed DNA Polymerase (genetics)
  • Diffuse Cerebral Sclerosis of Schilder (genetics)
  • Exons (genetics)
  • Fatal Outcome
  • Female
  • Heterozygote
  • Humans
  • Mutation
  • Oligonucleotide Array Sequence Analysis (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: